NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 324 filers reported holding NATERA INC in Q1 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $548,700 | -41.0% | 12,400 | -35.1% | 0.00% | -50.0% |
| Q2 2023 | $929,406 | -73.7% | 19,100 | -70.0% | 0.01% | -76.5% |
| Q1 2023 | $3,530,461 | -29.9% | 63,589 | -49.3% | 0.03% | -19.0% |
| Q4 2022 | $5,036,836 | -12.8% | 125,388 | -4.8% | 0.04% | -12.5% |
| Q3 2022 | $5,773,000 | -11.8% | 131,756 | -18.1% | 0.05% | -18.6% |
| Q1 2022 | $6,542,000 | +54.5% | 160,800 | +254.7% | 0.06% | +55.3% |
| Q4 2021 | $4,233,000 | -45.0% | 45,331 | -34.3% | 0.04% | -51.9% |
| Q3 2021 | $7,692,000 | -26.9% | 69,026 | -25.6% | 0.08% | -29.5% |
| Q2 2021 | $10,527,000 | -20.8% | 92,726 | -29.2% | 0.11% | -30.9% |
| Q1 2021 | $13,299,000 | +581.0% | 130,961 | +567.6% | 0.16% | +523.1% |
| Q4 2020 | $1,953,000 | -26.9% | 19,616 | -47.0% | 0.03% | -49.0% |
| Q3 2020 | $2,673,000 | +80.4% | 37,000 | +24.4% | 0.05% | +155.0% |
| Q2 2020 | $1,482,000 | +18.8% | 29,744 | -28.8% | 0.02% | -74.7% |
| Q1 2020 | $1,247,000 | -50.9% | 41,768 | -44.6% | 0.08% | +27.4% |
| Q4 2019 | $2,541,000 | +60.4% | 75,431 | +56.2% | 0.06% | +31.9% |
| Q3 2019 | $1,584,000 | +877.8% | 48,300 | +316.4% | 0.05% | +683.3% |
| Q4 2018 | $162,000 | – | 11,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |